Effects of olanzapine on regional c-fos expression in rat forebrain

Neuropsychopharmacology

Volumn 14, Issue 2, 1996, Pages 105-110

  Robertson, George S ^a   Fibiger, H Christian ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Atypical antipsychotics; c fos; Extrapyramidal side effects; Immediate early genes; Olanzapine; Schizophrenia

Indexed keywords

CLOZAPINE; OLANZAPINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ARTICLE; BRAIN STEM; BRAIN TISSUE; CORPUS STRIATUM; EXTRAPYRAMIDAL SYMPTOM; FOREBRAIN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIMBIC SYSTEM; MALE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 0030048254     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00196-K     Document Type: Article

References (35)

1. Baldessarini RJ (1990): Drugs and the treatment of psychiatric disorders. In Goodman AG, Ral TW, Nies AS, Taylor P (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. New York, Pergamon Press, pp 383-435
2. Baldessarini RJ, Frankenburg FR (1991): Clozapine: A novel antipsychotic. New Engl J Med 324:746-754
3. Beasley CM, Tollefson GD, Tran P, Satterlee W, Sanger T, Holman S, HGAD Olanzapine Study Group (1996): Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind Olanzapine trial. Neuropsychopharmacology 14:111-123
4. Berman KF, Zee RF, Weinberger DR (1986): Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 43:126-135
5. Bjerkenstedt L (1989): Melperone in the treatment of schizophrenia. Acta Psychiatr Scand Suppl 352:35-39
6. Borison RL, Hitri A, Blowers AJ, Diamond B (1983): Antipsychotic drug action: Clinical, biochemical, and pharmacological evidence for site specificity of action. Clinical Neuropharmacol 6:137-150
7. 2 receptor mRNA. Brain Res 564:203-219
8. Brodal A (1981): Neurological Anatomy in Relation to Clinical Medicine, 3rd ed. New York, Oxford University Press, pp 663-667
9. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore ND, Tye NC, Seeman P, Wong DT (1996): Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96
10. Carelli RM, West MO (1991): Representation of the body by single neurons in the dorsolateral striatum of the awake, unrestrained rat. J Comp Neurol 309:231-249
11. Claghorn J, Honigfeld G, Abuzzahab FS, Steinbook AR, Tuason V, Klerman G (1987): The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7:377-384
12. Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S (1992): Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: A multicenter double-blind comparative study. Acta Psychiatr Scand 85:295-305
13. Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS, Charney DS (1991): Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121-156
14. Deutch AY, Lee MC, Iadarola MJ (1992): Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci 3:332-341
15. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37:287-294
16. Franzen G, Ingvar DH (1974): Absence of activation in frontal structures during psychological testing of chronic schizophrenia. J Neurol Neurosurg Psychiatry 38:1027-1032
17. Guo N, Klitenick MA, Tham CS, Fibiger HC (1995): Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience 65:747-756
18. Heath RG (1975): Brain function and behavior. I. Emotional and sensory phenomena in psychotic patients and in experimental animals. J Nerv Ment Dis 160:159-175
19. Heath RG (1977): Modulation of emotion with a pacemaker: Treatment for intractable psychiatric illness. J Nerv Ment Dis 165:300-317
20. Idanpaan-Heikkela J, Alhaba J, Olkinuora M, Palva IP (1977): Agranulocytosis during treatment with clozapine. Eur J Clin Pharmacol 11:193-198
21. Kane J, Honigfeld G, Singer J, Meltzer H (1988): Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789-796
22. Krettek JE, Price JL (1978): Amygdaloid projections to subcortical structures within the basal forebrain in the rat and cat. J Comp Neurol 178:225-254
23. Meltzer H, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J (1989): A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report. Psychopharmacology 99:S68-S72
24. Merchant KM, Dorsa DM (1993): Differential induction of neurotensin and c-fos gene expression by typical and atypical antipsychotics. Proc Natl Acad Sci USA 90: 3447-3451
25. Moore NA, Tye NC, Axton MS, Risius F (1992): The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262:545-551
26. Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE (1992): Differential expression of c-fos and Zif 268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA 89:4270-4274
27. Pisa M (1988): Motor functions of the striatum of the rat: Critical role of the lateral region in tongue and forelimb reaching. Neuroscience 24:453-463
28. Robertson GS, Fibiger HC (1992): Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine. Neuroscience 46:315-328
29. Robertson GS, Matsumura H, Fibiger HC (1994): Induction patterns of neuroleptic-induced Fos-like immunoreactivity as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058-1066
30. Robertson GS, Tetzlaff W, Bedard A, St-Jean M, Wigle N (1995): C-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. Neuroscience 67:325-344
31. Shu S, Fan L (1988): The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85:169-171
32. Stockton ME, Rasmussen K (1996): Electrophysiological effects of olanzapine, a novel atypical antipsychotic on A9 and A10 dopamine neurons. Neuropsychopharmacology 14:97-104
33. Swanson LW, Cowan WM (1979): The connections of the septal region of the rat. J Comp Neurol 186:621-656
34. Thomas E (1988): Forebrain mechanisms in the relief of fear: The role of the lateral septum. Psychobiology 16:36-44
35. Weinberger DR (1988): Schizophrenia and the frontal lobe. Trends Neurosci 8:367-370